Shop- All categories
- Dermal fillers
- Imagene Fine Dermal Filler
Imagene Strong Dermal Filler
Imagene Strong Dermal Filler
In stock
In stock
Imagene Strong is a high-density cross-linked hyaluronic acid dermal filler designed for pronounced volume restoration, facial contouring and structural enhancement.
As the firmest product within the Imagene dermal filler range, it is formulated for treatments requiring greater projection and support. It contains 24mg/ml hyaluronic acid with 0.3% lidocaine and is designed for placement within deeper tissue layers. Its very firm gel consistency and approximately 900μm particle profile make it particularly suited to areas where definition, projection and volume restoration are required. Imagene Strong is supplied as a 1 × 1ml pre-filled syringe.
Key Benefits
Imagene Strong is the structural, high-projection option in the range:
-
- High-density cross-linked hyaluronic acid dermal filler
-
- Firmest formulation within the Imagene range
-
- 24mg/ml hyaluronic acid concentration
-
- Contains 0.3% lidocaine for treatment comfort
-
- Very firm gel consistency
-
- Approximately 900μm particle profile for high volumising capacity
-
- Manufactured using Hy-BRID technology
-
- Designed for strong projection and shape retention
-
- Suitable for chin, jawline and cheek contouring
-
- Designed for deeper tissue placement
-
- Supplied as a 1 × 1ml pre-filled syringe
-
- Professional-use product for trained practitioners only
Product Details
Key specifications for Imagene Strong:
-
- Product name: Imagene Strong
-
- Product type: Cross-linked hyaluronic acid dermal filler
-
- Hyaluronic acid concentration: 24mg/ml
-
- Lidocaine concentration: 0.3% / 3mg/ml
-
- Syringe size: 1ml
-
- Pack size: 1 × 1ml pre-filled syringe
-
- Technology: Hy-BRID
-
- Particle size: Approximately 900μm
-
- Gel consistency: Very firm
-
- Placement: Middle to deep / deep to very deep layer of the subcutis
-
- Medical device classification: Class III medical device
-
- Manufacturer: Genoss Co., Ltd.
-
- Use: Professional aesthetic use
Always check the physical packaging and current Instructions for Use for exact composition, batch number, expiry date, sterility status and regulatory markings before use.
What Is Imagene Strong?
Imagene Strong is a structural hyaluronic acid dermal filler developed for facial treatments requiring significant volume, projection and definition. It is the strongest and most volumising formulation within the Imagene range, designed to provide greater tissue support than lighter fillers, and is particularly suited to areas where practitioners require firm structural correction while maintaining controlled mouldability.
Hyaluronic Acid, Lidocaine and Hy-BRID Technology
Imagene Strong contains 24mg/ml of cross-linked hyaluronic acid — a substance that occurs naturally within human tissues and contributes to hydration, volume and structural support. When used appropriately, cross-linked HA can provide temporary volume restoration and contour enhancement; the effects are temporary and gradually reduce as the injected material is naturally metabolised.
The gel contains 0.3% lidocaine (3mg/ml) to help reduce discomfort during injection — practitioners must assess patients for relevant allergies, previous reactions to local anaesthetics and other contraindications before treatment. Manufactured using Hy-BRID technology, Imagene Strong is designed to produce dense, uniform HA particles with stable rheological characteristics, resulting in a firm filler that resists deformation while providing controlled projection. Its approximately 900μm particle profile contributes to high volumising capacity and firm consistency, making it suited to deeper tissue placement and treatments requiring stronger definition, with high volume capacity, strong projection, structural support, controlled mouldability and defined contouring. The product should only be selected where its rheological properties are appropriate for the treatment area and patient anatomy.
Suitable Treatment Areas
Imagene Strong may be selected by appropriately trained practitioners for facial contouring and volume restoration. Potential treatment areas may include:
-
- Chin augmentation and shaping
-
- Jawline definition
-
- Cheek and zygomatic contouring
-
- Facial volume restoration
-
- Nasal contouring where clinically appropriate
-
- Deep facial folds
-
- Areas requiring structural projection
-
- Areas requiring significant volume support
Its high-density gel can provide structural support in areas such as the chin, cheeks and jawline where practitioners may wish to create stronger definition or restore lost volume. The exact indication, treatment area, depth and technique must be determined by the treating practitioner in accordance with the manufacturer’s Instructions for Use and individual patient assessment, always respecting the patient’s natural anatomy and facial proportions.
Volume Restoration and Duration
Ageing and changes in facial fat distribution can contribute to loss of volume and structural support, and Imagene Strong may be used where a practitioner determines that deeper volume restoration is clinically appropriate. Published product information commonly describes an expected effect of approximately 9–12 months, though actual longevity varies considerably between patients and should not be guaranteed. Outcomes and duration depend on patient anatomy, age, skin quality, degree of volume loss, treatment area, injection technique, amount of product used, metabolism, lifestyle factors and previous aesthetic treatments.
Professional Consultation
An appropriate consultation and clinical assessment should be completed before treatment, including consideration of medical history, current medicines, previous aesthetic treatments and dermal fillers, known allergies, previous reactions to lidocaine, active infections, skin inflammation, relevant autoimmune or systemic conditions, pregnancy or breastfeeding status where relevant, patient expectations and suitability of the requested treatment. Treatment should not proceed where the practitioner identifies an appropriate contraindication or clinical concern.
Important Vascular Occlusion and Visual Loss Warnings
Dermal filler injection carries a rare but potentially serious risk of vascular compromise, which may occur following inadvertent intravascular injection or vascular compression. Potential warning signs may include disproportionate or increasing pain, blanching, mottling, dusky or abnormal skin colour, delayed capillary refill, skin cooling or progressive tissue changes. Practitioners must be appropriately trained in recognising and managing vascular complications and should have a current complication-management protocol immediately available.
Rare but severe visual complications have also been associated with facial dermal filler injections. Any sudden visual disturbance, visual loss, severe ocular symptoms or neurological changes during or following treatment should be treated as a medical emergency — treatment must be stopped immediately and the appropriate emergency and specialist referral pathway activated. The presence of an aesthetic complication kit must never delay urgent ophthalmic, neurological or hospital assessment. Imagene Strong must not be intentionally injected into blood vessels, and particular care is required when treating higher-risk anatomical areas; only practitioners appropriately trained and competent in the treatment area should administer the product.
Potential Treatment Reactions
Temporary injection-site reactions can occur, including redness, swelling, tenderness, bruising, itching, firmness, mild discomfort and temporary asymmetry — generally temporary, though duration varies. Less common but more serious complications can include infection, inflammatory reactions, nodules, delayed reactions, hypersensitivity reactions, vascular compromise, tissue injury and visual complications. Any severe, unexpected or progressively worsening symptoms require prompt clinical assessment.
Sterile Single-Use Product and Aseptic Technique
Imagene Strong is supplied as a sterile pre-filled glass syringe intended for single use only. Before use, check the packaging is intact, the syringe undamaged, the product within its expiry date, the gel normal in appearance and sterility not compromised. Do not use if the packaging is damaged or has previously been opened, and do not reuse or resterilise the syringe or supplied needles. Appropriate aseptic technique must be maintained throughout — prepare the treatment area, maintain suitable hand hygiene, use sterile equipment, avoid contamination of sterile components, use an appropriate sterile needle or cannula where permitted, and dispose of sharps immediately after treatment within an appropriate professional clinical environment.
Aftercare
Patients should receive appropriate post-treatment advice. Depending on the procedure, practitioners may advise temporary avoidance of intense physical exercise, alcohol, excessive heat, saunas, steam rooms, sunbeds, prolonged UV exposure, massage of the treated area and other aesthetic procedures affecting the treatment site. Patients should be informed of expected reactions and symptoms that require urgent review.
Storage and Disposal
Store Imagene Strong according to the manufacturer’s instructions — available product information specifies room temperature between approximately 1°C and 30°C. Keep the product in its original packaging until required, away from direct sunlight, protected from excessive heat and freezing, and secure from unauthorised access. Do not use after the stated expiry date. Used syringes and needles must be disposed of immediately into an approved sharps container, and unused or contaminated filler material disposed of according to appropriate clinical waste procedures.
Professional Use Only
Imagene Strong is a sterile, single-use Class III medical device manufactured by Genoss Co., Ltd., consisting of stabilised non-animal hyaluronic acid with lidocaine in a pre-filled glass syringe. It is intended for use by appropriately trained and qualified healthcare and aesthetic professionals and must not be self-administered. Purchase or possession does not establish competency to perform injectable aesthetic treatments — practitioners remain responsible for ensuring treatment is clinically appropriate, within their professional scope and competence, and performed in accordance with current professional guidance and the manufacturer’s Instructions for Use.
Quantity
1
Insurance for Imagene Strong Dermal Filler
Compare insurance quotes from trusted partners.
Get your quote
Meet your seller
MediSync
4.9 (48)
137 products
174 sold
We’re an MHRA licensed broker.All-in-one platform for aesthetic clinics. Manage bookings and digital consent easily. Reduce paperwork and save time. Secure client data and records. Built for modern practitioners.
Get in touch
